Novo Growth – 2021, A Year in Review

Copenhagen, Denmark, 22 April 2022 – Novo Growth, the growth-stage investment arm of Novo Holdings, today publishes its annual newsletter.

Commenting on a highly successful year, Robert Ghenchev, Managing Partner, Head of Novo Growth, said: “Novo Growth’s unique platform combines deep life sciences expertise with long-term capital to make significant growth equity investments in companies across the life sciences industry.

Read more…